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Objective: To compare associations of physical activity during daily life with treadmill walking performance and
corridor-based functional performance measures in persons with lower extremity peripheral arterial disease (PAD).
Study Design: Cross-sectional.
Subjects: One hundred fifty-six men and women with PAD who completed baseline measurements and were randomized
into the study to improve leg circulation (SILC) exercise clinical trial.
Main Outcome Measures: Participants completed a Gardner-Skinner treadmill protocol. Corridor-based functional
performance measures were the 6-minute walk, walking velocity over four meters at usual and fastest pace, and the short
physical performance battery (SPPB) (0-12 scale, 12  best). Physical activity during daily life was measured continu-
ously over 7 days with a Caltrac (Muscle Dynamics Fitness Network, Inc, Torrence, Calif) accelerometer.
Results: Adjusting for age, gender, and race, higher levels of physical activity during daily life were associated with greater
distance achieved in the 6-minute walk (P trend  .001), faster fast-paced four-meter walking velocity (P trend < .001),
faster usual-paced four-meter walking speed (P trend  .027) and a higher SPPB (P trend  .005). The association of
physical activity level with maximum treadmill walking distance did not reach statistical significance (P trend  .083).
There were no associations of physical activity with treadmill distance to onset of leg symptoms (P trend  .795).
Conclusion: Functional performance measures are more strongly associated with physical activity levels during daily life
than treadmill walking measures. ( J Vasc Surg 2008;48:1231-7.)Persons with lower extremity peripheral arterial disease
(PAD) have greater functional impairment and faster rates
of functional decline compared to persons without PAD.1-3
Identifying new therapies that improve functional perfor-
mance and prevent functional decline in patients with PAD
has the potential to significantly benefit the large and
growing number of men and women with PAD.
Treadmill walking performance is typically the primary
outcome in clinical trials evaluating medical therapies for
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However, the degree to which treadmill testing reflects
functional performance during daily life is unclear. Tread-
mill walking performance is measured in a highly controlled
setting. Treadmill protocol specifies initial walking velocity
and the rate of increase in walking speed and intensity. In
contrast, participants set their own pace in corridor-based
functional performance measures, such as the 6-minute
walk test. Therefore, treadmill protocols may represent a
relatively artificial measure of walking and may be a less
optimal measure of daily or usual walking performance than
corridor-based performance measures.
This study determined whether treadmill walking per-
formance and corridor-based functional performance, re-
spectively, were associated significantly with objectively-
measured physical activity during daily life among persons
with PAD.We hypothesized that corridor-based functional
performance measures would be more strongly associated
with physical activity during daily life than treadmill walk-
ing measures.
METHODS
Study overview. The study to improve leg circulation
(SILC) is a randomized controlled clinical trial testing the
ability of treadmill exercise and lower extremity resistance
training, respectively, to improve walking performance in
PAD participants with and without intermittent claudica-
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analyses. The study design is cross-sectional.
The institutional review boards of Northwestern Uni-
versity, Catholic Health Partners Hospital, Evanston
Northwestern Hospital, Rush Medical Center, University
of Illinois-Chicago, the Jesse Brown Veterans Administra-
tion Medical Center in Chicago, and Mt. Sinai Hospital in
Chicago approved the protocol. Participants gave written
informed consent. The funding source for this study played
no role in the design, conduct, reporting of the study, or
decision to submit the manuscript.
Participant identification. Potential participants were
recruited from among consecutive patients diagnosed with
PAD in the non-invasive vascular laboratories and from
relevant clinics (vascular surgery, cardiology, general med-
icine, geriatrics, and endocrinology) at Northwestern Me-
morial Hospital and other Chicago-area hospitals. Newspa-
per and radio advertisements, mailings to Chicago residents
age 60 and older, fliers, and other community outreach
methods were used to identify potentially eligible partici-
pants.
Inclusion and exclusion criteria. The inclusion crite-
rion was an ankle brachial index (ABI) 0.95. Exclusion
criteria and the number of potential participants meeting
each criterion are in Table I.
Ankle brachial index measurement. A hand-held
Doppler probe (Nicolet Vascular Pocket Dop II; Nicolet
Biomedical Inc, Golden, Colo) was used to obtain systolic
Table I. Exclusion criteria and number of potential
participants meeting each criterion in the study in
leg circulation
Exclusion criteria
Dementia (n  6)
Above or below knee amputation (n  1)
Foot ulcers or critical limb ischemia (n  6)
Nursing home residence or extreme frailty (n  8)
Inability to walk on a treadmill (n  5)
Inability to speak English (n  1)
Unable or unwilling to come to the medical center three times
weekly (n  57)*
Failure to complete six run-in exercise sessions in a 3-week
period (n  23)
Major surgery or a myocardial infarction during the previous 3
months (n  2)
Major surgery planned during the next year (n  12)
Current participation in other clinical trials (n  0)
Participant is already exercising at a level comparable to that
offered by either exercise arm of the trial (n  14)
Unstable angina (n  6)
Abnormal baseline stress test without a follow-up normal stress
imaging study (n  32)
Walking limitation due to a reason other than lower extremity
ischemia (n  24)
Baseline SPPB  12 (n  123)
Poorly controlled blood pressure (n  9)
*Includes potential participants who failed to show for initial study appoint-
ments.pressures in the right and left brachial, dorsalis pedis, andposterior tibial arteries.1-4 Each pressure was measured
twice: in the order listed and in reverse order. The ABI was
calculated by dividing the mean of the dorsalis pedis and
posterior tibial pressures in each leg by the mean of the four
brachial pressures.4 Average brachial pressures in the arm
with highest pressure were used when one brachial pressure
was higher than the opposite brachial pressure in both
measurement sets and the two brachial pressures differed by
10 mm Hg or more in at least one measurement set, since
in such cases subclavian stenosis was possible.5 The lowest
leg ABI was used in analyses.
Medical history. Medical history was obtained from
patient-report (see Appendix, online only). Participants
were asked whether a physician had ever told them that they
had angina, heart failure, diabetes, myocardial infarction,
disk disease, spinal stenosis, hip or knee arthritis, cancer, or
pulmonary disease.
Functional performance measures
Six-minute walk. The 6-minute walk test is a measure
of walking endurance that has excellent test re-test reliabil-
ity in persons with PAD.6-8 Following a standardized pro-
tocol,6-8 participants walk up and down a 100-foot hallway
for 6 minutes after instructions to cover as much distance as
possible. The distance completed during the 6-minutes is
recorded. The intra-class correlation coefficient for test
re-test reliability of the 6-minute walk was 0.90 (P .001)
in our laboratory among 155 PAD participants who com-
pleted the tests approximately 1-2 weeks apart.
Repeated chair rises. Participants sit in a straight-
backed chair with arms folded across their chest and stand
up five times consecutively as quickly as possible. Time to
complete five chair rises was measured.9,10
Standing balance. Participants were asked to hold
three increasingly difficult standing positions for 10 sec-
onds each: standing with feet together side-by-side and
parallel (side-by-side stand), standing with feet parallel with
the toes of one foot adjacent to and touching the heel of the
opposite foot (semi-tandem stand), and standing with one
foot directly in front of and touching the other (tandem
stand).9,10 Scores range from zero (unable to hold the
side-by-side stand for 10 seconds) to four (able to hold the
full tandem stand for 10 seconds).9,10
Four-meter walking velocity. Walking velocity over
four meters was measured with a four-meter walk per-
formed at “usual” and “fastest” pace. For the “usual” paced
walk, participants were instructed to walk at their usual
pace, “as if going down the street to the store.” Each walk
was performed twice. The faster walk in each pair was used
in analyses.9,10 The intra-class correlation coefficient for
test re-test reliability were 0.83 (P  .0001) for the usual
paced four-meter walk and 0.88 (P  .0001) for the fast
paced four-meter walk in our laboratory among 155 PAD
participants who completed the tests approximately 1-2
weeks apart.
Short physical performance battery. The short phys-
ical performance battery (SPPB) combines data from the
usual paced four-meter walking velocity, time to rise from a
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receive a zero score for each task they are unable to com-
plete. Scores of one to four are assigned for remaining tasks,
based upon quartiles of performance for over 6,000 partic-
ipants in the Established Populations for the Epidemiologic
Study of the Elderly.9,10 Scores are summed to obtain the
SPPB, ranging from 0 to 12.9,10 Test re-test reliability of
the summary performance score was 0.72 (P .001) in our
laboratory among 144 PAD participants who completed
the test approximately 1-2 weeks apart.
Treadmill walking performance
Maximal treadmill walking distance and distance to
onset of ischemic leg symptoms were measured using the
Gardner-Skinner protocol.11-13 Treadmill testing was ad-
ministered by an exercise physiologist blinded to study
hypotheses. Participants able to walk at least 2.0 miles per
hour (MPH) began exercising at 2.0MPH. Grade began at
zero and was increased by 2% every 2 minutes. Participants
unable to walk at least 2.0 MPH began at 0.5 MPH
(modified Gardner protocol). Speed was increased by 0.50
MPH every 2 minutes until the participant reached 2.0
MPH, after which speed was maintained at 2.0 MPH and
grade was increased by 2% every 2 minutes until the partic-
ipant was unable to continue. Previous study shows that the
test re-test intraclass reliability coefficient is 0.93 for maxi-
mum walking distance and 0.89 for distance to onset of leg
symptoms.11
Physical activity levels measured objectively over
7 days
Physical activity levels were measured objectively over 7
days using a vertical accelerometer (Caltrac, Muscle Dy-
namics Fitness Network, Inc, Torrence, Calif).14-16 The
Caltrac accelerometers are designed to calculate the num-
ber of kilocalories (Kcal) expended by combining data from
measured physical activity (vertical movement) with data
on each participant’s age, weight, height, and gender.
Kilocalories expended are dependent on intrinsic character-
istics of the individual, such as age, gender, and body mass
index (BMI). We aimed to compare actual physical activity
levels, rather than Kcals expended. Therefore, for each
participant we programmed identical values for age,
weight, height, and gender, allowing us to compare physi-
cal activity levels between participants irrespective of indi-
vidual variation in age, weight, height, and gender.14-16
Thus, the accelerometers measured “activity units” rather
than calories expended.14-16 After wearing activity moni-
tors continuously for 7 days, participants reported the
number of activity units and steps displayed on the acceler-
ometer by telephone and mailed their activity monitors
back to investigators. Simultaneously with the Caltrac ac-
celerometers, participants wore Digiwalker (Yamax Inc,
Tokyo, Japan) step counters continuously for 7 days.17,18
However, the Caltrac monitors were selected a priori as the
primary physical activity outcome measure because the
Caltrac monitors have been well validated as measures of
physical activity in persons with PAD.14-16Other measures
Height and weight were measured at the study visit.
The BMI was calculated as weight/(square of height in
meters). Smoking history was obtained by administration
of a standardized questionnaire. Leg symptoms were mea-
sured with the San Diego claudication questionnaire.19
Statistical analyses
Functional performance measures (6-minute walk,
four-meter walking velocity at usual and fastest pace) and
treadmill outcomes (maximal treadmill walking distance
and treadmill distance to onset of leg symptoms) were
divided into quartiles. Established categories for the SPPB
were used to define SPPB performance.10
To determine associations of functional performance
measures and treadmill walking performance with daily
physical activity, mean functional performance for each
quartile/category of physical activity were compared using
analyses of variance, adjusting for age, gender, and race.
Analyses were repeated with additional adjustment for co-
morbidities, BMI, ABI, leg symptoms, smoking, and tread-
mill protocol type (Gardner vs modified Gardner). We also
assessed associations of quartiles/categories of functional
performance measures with treadmill walking performance
(dependent variable), adjusting for age, gender, and race.
RESULTS
Of 485 persons who attended a baseline visit, 329 met
one or more exclusion criteria (Table II), leaving 156
participants. Baseline characteristics of the 156 eligible,
randomized participants are shown in Table II. Compari-
sons of Caltrac physical activity and Digiwalker step mea-
sures showed that the lowest quartile of Caltrac physical
activity (374 activity units) was comparable to 6,957
steps walked over 7 days while the highest quartile of
Caltrac physical activity (849 activity units) was compa-
rable to 24,655 steps walked over 7 days.
Table II shows patient characteristics across quartiles of
physical activity. Higher physical activity was associated
with younger age (P .023), a lower prevalence of diabetes
mellitus (P  .006), and a lower BMI (P  .004).
Fig 1 shows associations of physical activity levels with
corridor-based functional performance measures, adjusting
for age, gender, and race. Higher levels of physical activity
were associated with greater 6-minute walk distance (P
trend  .001), faster normal-paced four-meter walking
velocity (P trend  .027), faster rapid-paced four-meter
walking velocity (P trend .001), and a higher SPPB score
(P trend  .005), adjusting for age, gender, and race. The
association of physical activity level with maximum tread-
mill walking distance was nearly statistically significant (Fig
2). Physical activity level was not associated with treadmill
distance to onset of leg symptoms, adjusting for age, gen-
der, and race (Fig 2). After additional adjustment for co-
morbidities, BMI, ABI, leg symptoms, and smoking, only
rapid-paced four-meter walking velocity remained associ-
ated significantly with physical activity levels (first physical
vity a
a Cal
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activity quartile1.03 meters/second, third physical activ-
ity quartile 1.18 meters/second, fourth quartile 1.15
meters/second, (P trend  .006).
In additional descriptive analyses, we compared
Fig 1. Associations of functional performance measu
peripheral arterial disease (n  156).*
* Functional performance across quartiles of physical acti
activity was measured continuously for seven days using
Table II. Associations of quartiles of Caltrac-measured ph
Entire
Cohort
Caltrac
1st quartile
( 374)
Age (years) 70.6  10.3 72.8  9.9
Male 48% 46%
African American race 40% 43%
Ankle brachial index 0.61  0.17 0.60  0.18
Education level
Less than high school 10% 16%
High school/college degree 71% 68%
Professional/graduate degree 19% 16%
Body mass index (kg/m2) 30.2  6.8 31.9  7.1
Diabetes mellitus 44% 49
Current smoker 24% 32%
Angina 12% 11%
Myocardial infarction 22% 19%
Heart failure 14% 8%
Pulmonary disease 13% 14%
Statin use 63% 62%
Anti-platelet therapy 65% 60%
Beta-blocker 46% 49%
ACE inhibitor 41% 41%
Participant characteristics are shown across quartiles of physical activity, m
standard deviations are shown.corridor-based walking performance measures with max-imum treadmill walking distance and treadmill distance
to onset of leg symptoms, adjusting for age, gender,
and race (Table III). Greater 6-minute walk distance
(P trend  .001) and faster rapid-paced four-meter
walking velocity (P trend  .005) were associated with
ith physical activity during daily life in persons with
re shown. Data adjust for age, gender, and race. Physical
trac vertical accelerometer.
l activity levels with participant characteristics
artiles of Physical Activity Level
altrac Caltrac Caltrac
P-value
d quartile
74  609)
3rdquartile
( 609   849)
4thquartile
( 849)
.8  9.3 70.5  11.3 67.0  9.4 .023
54% 41% 47% .711
38% 32% 39% .818
8  0.15 0.64  0.16 0.64  0.20 .409
11% 3% 11% .259
70% 73% 72% .958
19% 24% 17% .803
.3  6.7 26.9  4.8 30.0  6.5 .004
65% 30% 31% .006
22% 22% 19% .554
19% 11% 9% .613
23% 27% 22% .873
16% 17% 14% .720
14% 11% 11% .959
68% 73% 50% .209
70% 68% 69% .748
54% 49% 36% .469
41% 49% 36% .744
ed objectively over 7 days by a Caltrac vertical accelerometer. Means andres wysica
Qu
C
2n
( 3
73
0.5
31
easurgreater maximal treadmill walking distance, adjusting for
a Cal
gende
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and the SPPB were not significantly associated with
maximum treadmill walking distance (Table III). Only
6-minute walk distance was associated significantly with
treadmill distance to onset of leg symptoms (P trend 
Fig 2. Associations of treadmill walking measures with
arterial disease (n  156).*
* Functional performance across quartiles of physical acti
activity was measured continuously for seven days using
Table III. Associations of corridor-based walking perform
and women with peripheral arterial disease*
Q
Quartile 1
268 meters 
Maximum treadmill walking distance
(meters) 277 (33)
Treadmill distance to onset of leg
symptoms (meters) 120 (21)
Quartile
Quartile 1
0.727 M/Sec 0
Maximum treadmill walking distance
(meters) 335 (36)
Treadmill distance to onset of leg
symptoms (meters) 135 (23)
Quartil
Quartile 1
(0.94 M/sec) (0
Maximum treadmill walking distance 304 (37)
Distance to onset of treadmill symptoms 112 (23)
Short physical p
Category 1 (0-4)
Maximum treadmill walking distance 317 (68)
Distance to onset of treadmill symptoms 181 (46)
*Data shown are maximal treadmill walking distance and treadmill distanc
measures. Means and standard errors are shown. Data are adjusted for age,.003) (Table III).DISCUSSION
Among 156 persons with PAD, our results show that
better performance on each of four measures of corridor-
based functional performance: 6-minute walk distance,
ical activity during daily life in persons with peripheral
re shown. Data adjust for age, gender, and race. Physical
trac vertical accelerometer.
with treadmill walking performance among 156 men
iles of 6-minute walk performance
uartile 2 Quartile 3 Quartile 4
- 326 meters 326 - 375 meters 375 meters P trend
93 (31) 399 (32) 516 (33) .001
19 (20) 152 (20) 214 (20) .003
ur-meter walking velocity (normal pace)
uartile 2 Quartile 3 Quartile 4
- 0.811 M/Sec 0.811 - 0.915 M/Sec 0.915 M/Sec
17 (34) 406 (34) 424 (35) .087
17 (20) 174 (20) 179 (21) .097
four-meter walking velocity (rapid pace)
uartile 2 Quartile 3 Quartile 4
1.08 M/sec) (1.08 - 1.23 M/sec) (1.23 M/sec)
39 (34) 407 (34) 436 (37) .005
36 (21) 171 (20) 182 (22) .072
mance battery categories (0-12 scale, 12  best)
gory 2 (5-8) Category 3 (9-11)
67 (35) 372 (22) .622
43 (20) 146 (12) .583
nset of ischemic leg symptoms across quartiles of functional performance
r, and race.phys
vity aance
uart
Q
268
2
1
s of fo
Q
.727
3
1
es of
Q
.94 -
3
1
erfor
Cate
3
1
e to owalking velocity at usual speed, walking velocity at fastest
JOURNAL OF VASCULAR SURGERY
November 20081236 McDermott et alspeed, and the SPPB were associated significantly with
higher physical activity levels during daily life. Maximum
treadmill walking distance and treadmill distance to onset
of leg symptoms were not associated significantly with
physical activity levels during daily life, although associa-
tions of maximum treadmill walking distance with physical
activity showed a trend toward statistical significance.
These findings indicate that performance on corridor-based
functional measures are more closely linked to physical
activity levels during daily life than treadmill walking per-
formance.
Treadmill walking performance is traditionally used to
measure changes in walking performance following thera-
peutic interventions among persons with PAD. Treadmill
testing has potential advantages that include monitoring of
study participants in a tightly controlled setting and use of
a standardized protocol that specifies initial treadmill speed
and grade and rates of increase in treadmill speed and grade
at precisely determined intervals, allowing direct compari-
sons between participants. However, treadmill testing cre-
ates a more “artificial” environment compared to corridor-
based functional measures, in which walking speed is
determined by the patient. Consistent with these differ-
ences, previous study in persons without PAD shows that
treadmill walking is associated with greater anxiety and
requires greater balance than corridor-based walking mea-
sures.20-22 For example, a previous study of 12 healthy
elderly volunteers (aged 71-80 years) and 12 healthy young
volunteers (aged 21-37) compared physiologic responses
during treadmill walking vs the 6-minute walk.20 The el-
derly group, but not the young group, had consistently
higher heart rates and slower step rates during treadmill
testing as compared to corridor walking.20 In a separate
study of 11 patients with chronic obstructive pulmonary
disease (COPD), the distance covered during the 6-minute
walk test was significantly greater than distance covered
during 6 minutes of treadmill walking (530 meters vs 481
meters, P  .01).21 Together these findings suggest that
treadmill testing may be less applicable to usual walking
ability in the community than corridor-based functional
performance measures.
Of the four corridor-based functional performance
measures studied, only the SPPB did not correlate signifi-
cantly with treadmill walking performance. In contrast to
the 6-minute walk, and the four-meter walking velocities,
the SPPB encompasses more direct measures of balance and
leg strength. These components of functioning appear to
be distinct from the outcomes of maximum treadmill walk-
ing distance and treadmill distance to onset of leg symp-
toms. Nonetheless, the baseline SPPB score predicts the
rate of mobility loss among persons with PAD.23 A baseline
SPPB score predicts mobility loss and mortality among
persons without PAD.9,10 Cross-sectional data reported
here show that better SPPB scores are associated with
higher physical activity levels. Together, these data suggest
that the SPPB outcome is distinct from treadmill walking
measures, but is nonetheless a well validated measure of
lower extremity performance in PAD persons.This study has limitations. First, data are cross-sectional.
This study could not determine whether treadmill walking
performance is more sensitive to the effects of interventions
than walking performance measures. One prior random-
ized controlled clinical trial demonstrated greater increases
in maximum treadmill walking performance than in
6-minute walk performance after a 6-month supervised
exercise intervention.24 Second, the exclusion criteria for
this study may limit the generalizability of the findings.
Third, participants with PAD included persons with and
without intermittent claudication symptoms. In contrast,
most clinical trials in persons with PAD are restricted to
those with classical symptoms of intermittent claudication.
In conclusion, findings reported here suggest that
corridor-based functional performance measures better re-
flect usual physical activity levels during daily life than
treadmill walking performance. Our findings suggest that
corridor-based functional performance measures are an im-
portant complement to treadmill walking performance and
may better reflect certain aspects of usual walking during
daily life than treadmill walking performance. Future stud-
ies of performance in persons with PAD should include
measures of corridor-based functional performance, rather
than only treadmill-based performance.
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1. Do you now or have you ever smoked cigarettes?
1a. If “Yes”:
- Years ago quit?
- How many years have/did you smoke?
- How many packs per day (past or current)?
2. Has a doctor ever told you that you had diabetes?
3. Has a doctor ever told you that you had angina or chest
pain due to heart disease?
4. Has a doctor ever told you that you had a heart attackor myocardial infarction?5. Has a doctor ever told you that you had heart failure or
congestive heart failure?
6. Has a doctor ever told you that you have lung disease
such as emphysema or chronic bronchitis?
7. Has a doctor told you that you had cancer?
If yes, determine type of cancer – list all types and
year.
8. Has a doctor ever told you that you had arthritis in
your knees?
9. Has a doctor ever told you that you had arthritis in
your hips?
10. Has a doctor ever told you that you had spinal stenosis?
11. Has a doctor ever told you that you had a degenerated,slipped, or herniated disc or sciatica?
